These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15273367)

  • 1. Glycobiology. Synthetic vaccine is a sweet victory for Cuban science.
    Kaiser J
    Science; 2004 Jul; 305(5683):460. PubMed ID: 15273367
    [No Abstract]   [Full Text] [Related]  

  • 2. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
    Verez-Bencomo V; Fernández-Santana V; Hardy E; Toledo ME; Rodríguez MC; Heynngnezz L; Rodriguez A; Baly A; Herrera L; Izquierdo M; Villar A; Valdés Y; Cosme K; Deler ML; Montane M; Garcia E; Ramos A; Aguilar A; Medina E; Toraño G; Sosa I; Hernandez I; Martínez R; Muzachio A; Carmenates A; Costa L; Cardoso F; Campa C; Diaz M; Roy R
    Science; 2004 Jul; 305(5683):522-5. PubMed ID: 15273395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
    Mawas F; Newman G; Burns S; Corbel MJ
    J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
    Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
    Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
    Pace D; Snape M; Westcar S; Hamaluba M; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ
    Pediatr Infect Dis J; 2007 Nov; 26(11):1057-9. PubMed ID: 17984816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships among physico-chemical and biological tests for a synthetic Hib-TT conjugate vaccine.
    Cuervo ML; Pérez LR; Oviedo M; Costa L; Perdomo V
    Vaccine; 2007 Jan; 25(1):194-200. PubMed ID: 17161239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell dependent and T-cell independent antibody response to bacterial polysaccharides in patients with IgG2 deficiency.
    Bartmann P; Freihorst J; Seger R; Schmitt M; Wahn U; Wahn V; Jager H
    Immunodeficiency; 1993; 4(1-4):59-61. PubMed ID: 8167735
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental design to optimize an Haemophilus influenzae type b conjugate vaccine made with hydrazide-derivatized tetanus toxoid.
    Laferriere C; Ravenscroft N; Wilson S; Combrink J; Gordon L; Petre J
    Glycoconj J; 2011 Oct; 28(7):463-72. PubMed ID: 21850577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of functional Haemophilus influenzae type b antibodies after vaccination.
    van der Velden AM; Claessen AM; van Velzen-Blad H; Biesma DH; Rijker GT
    Haematologica; 2005 Nov; 90(11):1582-4. PubMed ID: 16266910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants.
    Pöllabauer EM; Petermann R; Ehrlich HJ
    Vaccine; 2009 Mar; 27(11):1674-9. PubMed ID: 19168106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.
    Ribeiro GS; Lima JB; Reis JN; Gouveia EL; Cordeiro SM; Lobo TS; Pinheiro RM; Ribeiro CT; Neves AB; Salgado K; Silva HR; Reis MG; Ko AI
    Vaccine; 2007 May; 25(22):4420-8. PubMed ID: 17449150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
    J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteria, polysaccharides, vaccines and boosting: measuring and maintaining population immunity.
    Goldblatt D
    Arch Dis Child; 2008 Aug; 93(8):646-7. PubMed ID: 18644932
    [No Abstract]   [Full Text] [Related]  

  • 17. [Validation of an ELISA assay for the quantification of antibodies against Haemophilus influenzae type b capsular polysaccharide].
    Toraño Peraza G; Hernández Vadell I; Baly A; Toledo Romaní ME
    Rev Cubana Med Trop; 2005; 57(3):185-91. PubMed ID: 17969271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda.
    Muganga N; Uwimana J; Fidele N; Gahimbare L; Gessner BD; Mueller JE; Mhlanga BR; Katsande R; Herbinger KH; Rugambwa C
    Vaccine; 2007 Sep; 25(39-40):7001-5. PubMed ID: 17709159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.